Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.

Researchers

A

Albert González Martin

Dermatologist
A

Anna Ravella Matthew

Dermatologist
PhD
D

David Vidal Sarro

Dermatologist
PhD
G

Gisela Hebe Petiti

Dermatologist
J

Joan Antoni Smandia Domínguez

Dermatologist
PhD
L

Laura Peramiquel Fonollosa

Dermatologist

L

Loida Galvany Rosell

Dermatologist
M

Mª Rosa Olivella Garcés

Dermatologist
M

Maria López Nuñez

Dermatologist
M

Maria Villar Buil

Dermatologist
N

Nuria Lamas Domenech

Dermatologist

Contact the group

Form

Belinchón I, Queiro R, Salgado-Boquete L, López-Ferrer A, Ferran M, Coto-Segura P, Rivera R, Vidal D, Rodríguez L, de la Cueva P, Guinea G, Martin Vazquez V. 198/20

Linguistic and cultural adaptation to Spanish of the psoriatic arthritis screening questionnaire PURE-4 questionnaire.

Actas Dermosifiliogr. 2020;111:655-664.

DOI
Podlipnik S, Carrera C, Boada A, Richarz N, Marcoval J, Ferreres JR, Bodet D, Martí RMª, Segura S, Sabat M, Dalmau J, Quintana M, Azon A, Curcó N, Formigon M, Olivella-Garcés MªR, Zaballos P, Sola J, Galvany L, Baliu-Piqué C, Alegre M, Pasquali P, Malvehy J and Puig S, on behalf of the Network of Melanoma Centers of Catalonia. 254/20

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

J Clin Med. 2020 Oct 23;9(11):3396. doi: 10.3390/jcm9113396.
Romaní J, Giavedoni P, Roé E, Vidal D, Luelmo J, Wortsman X. 255/20

Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis.

J Ultrasound Med. 2020 Jan;39(1):107-112. doi: 10.1002/jum.15080. Epub 2019 Jun 27.
Del Alcázar E, Suárez-Pérez J, Armesto S, Rivera R, Herrera-Acosta E, Herranz P, Martín I, Montesinos E, Hospital M, Vilarrasa E, Ferran M, Ruiz-Villaverde R, Sahuquillo-Torralba A, Ruiz- Genao D, Pérez-Barri S, Muñoz C, Llamas M, Valentí F, Mitxelena M, López-Ferrer A, Carretero G, Vidal D, Mollet J, Belinchón I, Carrascosa JM. 294/20

Real-world Effectiveness and Safety of Apremilast in Psoriasis at 52 Weeks:

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2821-2829. doi: 10.1111/jdv.16439. Epub 2020 Jun 17.
Rivera R, Velasco M, Vidal D, Carrascosa JM, Daudén E, Vilarrasa E, Notario J, Ruíz-Villaverde R, Yanguas I, García-Latasa FJ, Ferrán M, Lázaro-Simó A, de la Cueva P, Salgado-Boquete L, Belinchón I. 317/20

The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.

Dermatol Ther. 2020 Nov;33(6):e14066. doi: 10.1111/dth.14066. Epub 2020 Sep 3.
Belinchón I, Queiro R, Salgado-Boquete L, López-Ferrer A, Ferran M, Coto-Segura P, Rivera R, Vidal D, Rodríguez L, de la Cueva P, Guinea G, Martin Vazquez V. 198/20

Linguistic and cultural adaptation to Spanish of the psoriatic arthritis screening questionnaire PURE-4 questionnaire.

Actas Dermosifiliogr. 2020;111:655-664.
Podlipnik S, Carrera C, Boada A, Richarz N, Marcoval J, Ferreres JR, Bodet D, Martí RMª, Segura S, Sabat M, Dalmau J, Quintana M, Azon A, Curcó N, Formigon M, Olivella-Garcés MªR, Zaballos P, Sola J, Galvany L, Baliu-Piqué C, Alegre M, Pasquali P, Malvehy J and Puig S, on behalf of the Network of Melanoma Centers of Catalonia. 254/20

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

J Clin Med. 2020 Oct 23;9(11):3396

DOI
Romaní J, Giavedoni P, Roé E, Vidal D, Luelmo J, Wortsman X. 255/20

Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis.

J Ultrasound Med. 2020 Jan;39(1):107-112
Del Alcázar E, Suárez-Pérez J, Armesto S, Rivera R, Herrera-Acosta E, Herranz P, Martín I, Montesinos E, Hospital M, Vilarrasa E, Ferran M, Ruiz-Villaverde R, Sahuquillo-Torralba A, Ruiz- Genao D, Pérez-Barri S, Muñoz C, Llamas M, Valentí F, Mitxelena M, López-Ferrer A, Carretero G, Vidal D, Mollet J, Belinchón I, Carrascosa JM.

Real-world Effectiveness and Safety of Apremilast in Psoriasis at 52 Weeks:

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2821-2829

DOI
Rivera R, Velasco M, Vidal D, Carrascosa JM, Daudén E, Vilarrasa E, Notario J, Ruíz-Villaverde R, Yanguas I, García-Latasa FJ, Ferrán M, Lázaro-Simó A, de la Cueva P, Salgado-Boquete L, Belinchón I. 317/20

The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.

Dermatol Ther. 2020 Nov;33(6):e14066.

DOI

Projects

Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Cross-sectional and retrospective study of clinical histories to evaluate the intensity of psoriasis in Spanish patients with moderate to severe psoriasis who routinely receive systemic treatment. CRYSTAL studio.
- DISTRICT ATTORNEY:
  
  AbbVie España SLU
- TYPE E:
  
  EPA-OD
Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Phase 3, randomized, double-blind, multicenter study to evaluate the efficacy and safety of ABP 654 compared to ustekinumab in subjects with moderate or severe plaque psoriasis.
- DISTRICT ATTORNEY:
  
  Amgen Inc.
- TYPE E:
  
  RD2015
Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
CROSS-SECTIONAL OBSERVATIONAL AND MULTICENTER STUDY FOR THE VALIDATION OF THE SPANISH VERSION OF THE PURE-4 QUESTIONNAIRE.
- DISTRICT ATTORNEY:
  
  Novartis pharmaceutical, SA
- TYPE E:
  
  PIN-NO EPA
Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, observational and prospective study to evaluate the efficacy of certolizumab pegol in patients with moderate or severe plaque psoriasis in daily practice (CIMREAL)
- DISTRICT ATTORNEY:
  
  UCB Biopharma SPRL
- TYPE E:
  
  EPA-SP
Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital/Dos de Maig Hospital Integral Care Center
Description of the skin manifestations of Covid-19.
- DISTRICT ATTORNEY:
  
  Dr. Gregorio Carretero Hernández of the University Hospital of Gran Canaria Dr. Negrín
- TYPE E:
  
  EPA-OD
Dermatologist

Researcher
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Implementation of the network of non-melanoma skin cancer centers.
- DISTRICT ATTORNEY:
  
  Dr. Agustín Toll Abe - Melanoma Unit at the Hospital Clínic de Barcelona
- TYPE E:
  
  PI
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Phase 3, randomized, double-blind, multicenter study to evaluate the efficacy and safety of ABP 654 compared to ustekinumab in subjects with moderate or severe plaque psoriasis.
- DISTRICT ATTORNEY:
  
  Amgen Inc.
- TYPE E:
  
  RD2015
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
CROSS-SECTIONAL OBSERVATIONAL AND MULTICENTER STUDY FOR THE VALIDATION OF THE SPANISH VERSION OF THE PURE-4 QUESTIONNAIRE.
- DISTRICT ATTORNEY:
  
  Novartis pharmaceutical, SA
- TYPE E:
  
  PIN-NO EPA
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, observational and prospective study to evaluate the efficacy of certolizumab pegol in patients with moderate or severe plaque psoriasis in daily practice (CIMREAL)
- DISTRICT ATTORNEY:
  
  UCB Biopharma SPRL
- TYPE E:
  
  EPA-SP
- Year 2020
- Sant Joan Despí Moisès Broggi Hospital/Dos de Maig Hospital Integral Care Center
Description of the skin manifestations of Covid-19.
- DISTRICT ATTORNEY:
  
  Dr. Gregorio Carretero Hernández of the University Hospital of Gran Canaria Dr. Negrín
- TYPE E:
  
  EPA-OD

Lines of action

Immune mediated skin diseases
Skin cancer
neurofibromatosis
Ultrasonography

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR cookie consent plugin, this cookie is used to record the user's consent to cookies in the "Ad" category.
cookielawinfo checkbox analytics	1 year	Set by the GDPR cookie consent plugin, this cookie is used to record the user's consent to cookies in the "Analytics" category.
cookielawinfo checkbox functional	1 year	The cookie is set by the GDPR cookie consent plugin to record the user's consent to cookies in the "Functional" category.
cookielawinfo-checkbox-Necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-fastrs	1 year	Set by the GDPR cookie consent add-on, this cookie is used to store the user's consent to cookies in the "Other" category.
cookielawinfo checkbox performance	1 year	Set by the GDPR cookie consent add-on, this cookie is used to store the user's consent for cookies in the "Performance" category.
CookieLawInfoConsent	1 year	Record the default button state of the corresponding category & the CCPA state. It only works in coordination with the main cookie.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also tracks site usage for the site analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_5515H28R8E	2 years	This cookie is installed by Google Analytics.

Dermatologist

Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.

Researchers

Albert González Martin

Anna Ravella Matthew

David Vidal Sarro

Gisela Hebe Petiti

Joan Antoni Smandia Domínguez

Laura Peramiquel Fonollosa

Loida Galvany Rosell

Mª Rosa Olivella Garcés

Maria López Nuñez

Maria Villar Buil

Nuria Lamas Domenech

Contact the group

Linguistic and cultural adaptation to Spanish of the psoriatic arthritis screening questionnaire PURE-4 questionnaire.

Actas Dermosifiliogr. 2020;111:655-664.

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

J Clin Med. 2020 Oct 23;9(11):3396. doi: 10.3390/jcm9113396.

Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis.

J Ultrasound Med. 2020 Jan;39(1):107-112. doi: 10.1002/jum.15080. Epub 2019 Jun 27.

Real-world Effectiveness and Safety of Apremilast in Psoriasis at 52 Weeks:

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2821-2829. doi: 10.1111/jdv.16439. Epub 2020 Jun 17.

The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.

Dermatol Ther. 2020 Nov;33(6):e14066. doi: 10.1111/dth.14066. Epub 2020 Sep 3.

Linguistic and cultural adaptation to Spanish of the psoriatic arthritis screening questionnaire PURE-4 questionnaire.

Actas Dermosifiliogr. 2020;111:655-664.

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

J Clin Med. 2020 Oct 23;9(11):3396

Inter- and Intra-rater Agreement of Dermatologic Ultrasound for the Diagnosis of Lobular and Septal Panniculitis.

J Ultrasound Med. 2020 Jan;39(1):107-112

Real-world Effectiveness and Safety of Apremilast in Psoriasis at 52 Weeks:

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2821-2829

The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.

Dermatol Ther. 2020 Nov;33(6):e14066.

Projects

Dermatologist

Researcher

Cross-sectional and retrospective study of clinical histories to evaluate the intensity of psoriasis in Spanish patients with moderate to severe psoriasis who routinely receive systemic treatment. CRYSTAL studio.

DISTRICT ATTORNEY:

AbbVie España SLU

TYPE E:

EPA-OD

Dermatologist

Researcher

Phase 3, randomized, double-blind, multicenter study to evaluate the efficacy and safety of ABP 654 compared to ustekinumab in subjects with moderate or severe plaque psoriasis.

DISTRICT ATTORNEY:

Amgen Inc.

TYPE E:

RD2015

Dermatologist

Researcher

CROSS-SECTIONAL OBSERVATIONAL AND MULTICENTER STUDY FOR THE VALIDATION OF THE SPANISH VERSION OF THE PURE-4 QUESTIONNAIRE.

DISTRICT ATTORNEY:

Novartis pharmaceutical, SA

TYPE E:

PIN-NO EPA

Dermatologist

Researcher

Multicenter, observational and prospective study to evaluate the efficacy of certolizumab pegol in patients with moderate or severe plaque psoriasis in daily practice (CIMREAL)

DISTRICT ATTORNEY:

UCB Biopharma SPRL

TYPE E:

EPA-SP

Dermatologist

Researcher

Description of the skin manifestations of Covid-19.

DISTRICT ATTORNEY:

Dr. Gregorio Carretero Hernández of the University Hospital of Gran Canaria Dr. Negrín

TYPE E:

EPA-OD

Dermatologist

Researcher

Implementation of the network of non-melanoma skin cancer centers.

DISTRICT ATTORNEY:

Dr. Agustín Toll Abe - Melanoma Unit at the Hospital Clínic de Barcelona

TYPE E:

PI

Phase 3, randomized, double-blind, multicenter study to evaluate the efficacy and safety of ABP 654 compared to ustekinumab in subjects with moderate or severe plaque psoriasis.

DISTRICT ATTORNEY: